Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI).

@article{Ribas1996EarlyRO,
  title={Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI).},
  author={Angeles Ribas and Joaquim Bellmunt and J 1137 Albanell and Ines Maria de Torres and Bego{\~n}a Bermejo and Juan Pablo Abugattas de Torres and J M S{\'a}nchez Morote and Enrique Gallardo and R Vera and Joan Carulla and L A Sol{\'e}-Calvo},
  journal={Tumori},
  year={1996},
  volume={82 6},
  pages={554-9}
}
AIMS AND BACKGROUND Several reports on prognostic factors for infiltrating-bladder cancer have given controversial results. We assessed the prognostic value of p53 nuclear overexpression together with known prognostic factors for survival in patients with invasive T2-4 N0 M0 bladder cancer treated with neoadjuvant chemotherapy. STUDY DESIGN Thirty-five… CONTINUE READING